NCT00249444 arm group 239db33cec318eea00cbd71cf58cc993 [clinicaltrials_resource:NCT00249444/arm-group/239db33cec318eea00cbd71cf58cc993]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00249444 arm group 239db33cec318eea00cbd71cf58cc993 [clinicaltrials_resource:NCT00249444/arm-group/239db33cec318eea00cbd71cf58cc993]
Bio2RDF identifier
NCT00249444/arm-group/239db33cec318eea00cbd71cf58cc993
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 9db33cec318eea00cbd71cf58cc993
description [clinicaltrials_vocabulary:description]
Mirtazapine will be administer ...... or the maximum tolerated dose.
identifier
clinicaltrials_resource:NCT00249444/arm-group/239db33cec318eea00cbd71cf58cc993
title
NCT00249444 arm group 239db33cec318eea00cbd71cf58cc993
@en
type
label
NCT00249444 arm group 239db33c ...... db33cec318eea00cbd71cf58cc993]
@en